止血剤と組織シーリング剤の市場規模、シェア、成長分析：製品別、材料別、用途別、最終用途別、地域別 - 産業予測 2025年～2032年

止血剤と組織シーリング剤の世界市場規模は2023年に74億1,000万米ドルと評価され、2024年の80億1,000万米ドルから2032年には149億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.1％で成長する見通しです。

世界の止血剤と組織シーリング剤市場は、慢性疾患の増加と高齢化によって外科手術の需要が増加し、力強い成長を遂げています。このような外科手術の急増により、患者の安全性を高めるための効果的な止血とシーリング製品が必要とされています。低侵襲手術や高度な手術手技の革新は、この需要をさらに増大させています。メーカーによる継続的な研究開発投資により、効能が強化され副作用の少ない革新的な製品が生み出され、ヘルスケア専門家の信頼を得ています。しかし、市場は厳しい規制当局の承認、高いヘルスケアコスト、償還の問題などの課題に直面しており、新技術の採用を妨げる可能性があります。さらに、競合企業間の激しい競争は価格圧力につながり、市場での存在感を維持するためには研究とマーケティング戦略への継続的な投資が必要となります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 原材料の分析

止血剤と組織シーリング剤市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 局所止血剤
  • 動的
  • 機械的
  • 流動性
• 接着剤および組織シーラント
  • 合成組織シーラント
  • 天然組織シーラント
  • 癒着防止剤

止血剤と組織シーリング剤市場規模：材料別& CAGR（2025-2032）

• 市場概要
• ゼラチンベースの局所止血剤
• コラーゲンベースの局所止血剤
• ORCベースの局所止血剤
• 多糖類ベースの局所止血剤

止血剤と組織シーリング剤市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 一般外科
• 脳神経外科
• 血管外科
• 心臓血管外科
• その他

止血剤と組織シーリング剤市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 病院
• 外来手術センター
• ホームケア設定
• その他

止血剤と組織シーリング剤市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Johnson & Johnson（United States）
• Baxter International Inc.（United States）
• Pfizer Inc.（United States）
• Integra LifeSciences Corporation（United States）
• Smith & Nephew plc（United Kingdom）
• B. Braun Melsungen AG（Germany）
• CryoLife, Inc.（United States）
• CSL Behring（Australia）
• Medtronic plc（Ireland）
• Zimmer Biomet Holdings, Inc.（United States）
• Ferrosan Medical Devices A/S（Denmark）
• Cohera Medical, Inc.（United States）
• Marine Polymer Technologies, Inc.（United States）
• Equimedical B.V.（Netherlands）
• Advanced Medical Solutions Group plc（United Kingdom）
• Cohesion Technologies, Inc.（United States）
• HyperBranch Medical Technology, Inc.（United States）
• Terumo Corporation（Japan）
• Mil Laboratories Pvt. Ltd.（India）

結論と推奨事項

Global Hemostasis and Tissue Sealing Agents Market size was valued at USD 7.41 billion in 2023 and is poised to grow from USD 8.01 billion in 2024 to USD 14.94 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global hemostasis and tissue sealing agents market is witnessing robust growth, fueled by rising chronic disease incidences and an aging demographic, which increases the demand for surgical procedures. This surge in surgeries necessitates effective hemostatic and sealing products to enhance patient safety. Innovations in minimally invasive surgery and advanced surgical techniques further amplify this demand. Continuous R&D investments by manufacturers are resulting in innovative products with enhanced efficacy and minimal side effects, earning the trust of healthcare professionals. However, the market faces challenges, including stringent regulatory approvals, high healthcare costs, and reimbursement issues, which could hinder the adoption of new technologies. Additionally, intense competition among players leads to pricing pressures, requiring ongoing investments in research and marketing strategies to sustain market presence.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemostasis And Tissue Sealing Agents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemostasis And Tissue Sealing Agents Market Segments Analysis

Global Hemostasis and Tissue Sealing Agents Market is segmented by Product, Material, Application, End-use and region. Based on Product, the market is segmented into Topical Hemostats and Adhesive & Tissue Sealant. Based on Material, the market is segmented into Gelatin-based Topical Hemostats, Collagen-based Topical Hemostats, ORC-based Topical Hemostats and Polysaccharide-based Topical Hemostats. Based on Application, the market is segmented into General Surgery, Neurosurgery, Vascular Surgery, Cardiovascular Surgery and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Home Care Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hemostasis And Tissue Sealing Agents Market

The increasing inclination towards minimally invasive surgical methods has significantly heightened the demand for specialized hemostasis and tissue sealing agents utilized in laparoscopic, endoscopic, and robotic-assisted procedures. These agents are crucial in achieving effective hemostasis and securing tissue closure during surgeries that prioritize reduced invasiveness. Their ability to enhance surgical outcomes and minimize complications has made them essential in contemporary surgical practices. As the medical field continues to emphasize patient comfort and faster recovery times, the global market for these innovative hemostatic and sealing agents is expected to grow, reflecting the evolving landscape of surgical techniques and patient care.

Restraints in the Global Hemostasis And Tissue Sealing Agents Market

The Global Hemostasis and Tissue Sealing Agents market faces notable constraints stemming from the lengthy and expensive approval process associated with new products. Stringent regulatory standards necessitate extensive testing and documentation, which can significantly impede the introduction of innovative agents. As a result, the development cycle is prolonged, leading to delays in the commercialization of new offerings. This not only restricts market growth but also limits the availability of advanced treatments for patients, ultimately affecting the competitive landscape in this vital industry. Consequently, manufacturers may encounter challenges in bringing their products to market efficiently.

Market Trends of the Global Hemostasis And Tissue Sealing Agents Market

The Global Hemostasis and Tissue Sealing Agents market is experiencing a robust trend fueled by the rising preference for minimally invasive surgical procedures. This shift is largely driven by the benefits these techniques offer, including reduced incision sizes, minimized scarring, and expedited recovery times for patients. Consequently, there is an increasing demand for specialized hemostasis and tissue sealing agents that ensure optimal wound closure and effective tissue adhesion during these surgeries. As healthcare providers continue to adopt advanced surgical methodologies, the market for these agents is expected to expand significantly, presenting lucrative opportunities for manufacturers and suppliers in the region.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Raw Material Analysis

Global Hemostasis and Tissue Sealing Agents Market Size by Product & CAGR (2025-2032)

• Market Overview
• Topical Hemostats
  • Active
  • Mechanical
  • Flowable
• Adhesive & Tissue Sealant
  • Synthetic Tissue Sealant
  • Natural Tissue Sealant
  • Adhesion Barrier Products

Global Hemostasis and Tissue Sealing Agents Market Size by Material & CAGR (2025-2032)

• Market Overview
• Gelatin-based Topical Hemostats
• Collagen-based Topical Hemostats
• ORC-based Topical Hemostats
• Polysaccharide-based Topical Hemostats

Global Hemostasis and Tissue Sealing Agents Market Size by Application & CAGR (2025-2032)

• Market Overview
• General Surgery
• Neurosurgery
• Vascular Surgery
• Cardiovascular Surgery
• Others

Global Hemostasis and Tissue Sealing Agents Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Home Care Settings
• Others

Global Hemostasis and Tissue Sealing Agents Market Size & CAGR (2025-2032)

• North America (Product, Material, Application, End-use)
  • US
  • Canada
• Europe (Product, Material, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Material, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Material, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Material, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Behring (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferrosan Medical Devices A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohera Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marine Polymer Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Equimedical B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Medical Solutions Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohesion Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HyperBranch Medical Technology, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mil Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations